A history exceeding
20 Years
Depth of research surpassing
150,000 Articles
Read and referenced, topping
14 Million Article Views
We don’t underwrite or manage assets
100% Unbiased

Award-Winning, Completely Unbiased Research

On the investment grade and high yield securities of issuers around the globe.
Select an article to download a free piece of research.

U.S. Consumer: Spending in the Age of Covid

Asia Credit: Inflation Winners and Losers

Cars in lot

Volvo Car: Looking to Issue €500 mn, 6Y WNG Bond

Markets Served

We’re proud to be the trusted resource for these credit research consumers:


From mutual funds, pensions and hedge funds to the world’s largest insurers, managers at these institutions are guided by our credit research


Financial intermediaries-the world’s broker-dealers, market makers and liquidity providers-rely on our credit insights each day


Brokers, financial advisors and private wealth managers entrusted with their clients’ assets leverage our intellectual capital when it comes to the credit markets

The Authority on Credit Markets

We’re the leading voice on global credit issuance, turning complexity into clarity in an ever-changing market.

Request a Trial

Receive complimentary access to our CreditSights research platform, where you can browse our library of expert-produced insights and reporting. Qualifying institutions can gain access to our platform for a 1-month trial.


Follow Us On Twitter

In light of our upgraded view on U.S. IG credit to Outperform (June 27th), we surveyed our U.S. investment grade team for their sector views and current bond picks and pans.

Read our picks and pans here: https://hubs.li/Q01fT0Z40

#IG #PicksandPans

Spreads widened across the Airline sector on investor recessionary fears and flight cancellation headlines, despite management guiding to a record 2Q22. We review our outlook on US Airlines as we head into 2H22.

Read our full outlook here: https://hubs.li/Q01fPV3H0

For Euro IG investors looking for compelling credits at wider spreads, we highlight five BBB issuers where positive fundamental momentum or specific positive catalysts leave our analyst team with a constructive view.
Read the full article here: https://www.creditsights.com/articles/454587

With drug pricing scrutiny front and center ahead of midterm elections, we break down the FTC's scrutiny of Pharmacy Benefit Managers and their role in pharmacy drug price inflation.

Read our full report here: https://hubs.li/Q01fnFCl0

We have compiled FAQs based on several client inquiries received on our trading ideas in the China IG industrial and tech sectors.
Read here for more: https://www.creditsights.com/articles/453838

We review the Aussie majors with the backdrop of rising interest rates, high household leverage, and falling house prices. We like these banks for their strong franchises, capitalization, and IG ratings down the capital spectrum. Read here for more: https://www.creditsights.com/articles/453969

Know More. Risk Better.®

Sign up to receive our latest credit insights direct to your inbox.